Table 3.
Risk of Poor LDL Control (≥100 mg/dL) by KP.org Refill Function Use, Among Those Non-Adherent to Statins at Baseline (n=3,887)
| Fully Adjusted† | +Mediation by Follow-up Adherence∫ | |||
|---|---|---|---|---|
| RR (95% CI) | RD (95% CI) | RR (95% CI) | RD (95% CI) | |
| No refill function use (Ref) | -- | -- | -- | -- |
| Occasional use | 0.99 (0.86, 1.15) | −0.002 (−0.03, 0.03) | 1.00 (0.86, 1.15) | −0.001 (−0.03, 0.03) |
| Exclusive use | 0.70 (0.56, 0.87)* | −0.06 (−0.09, −0.03)* | 0.75 (0.60, 0.94)* | −0.04 (−0.08, −0.01)* |
p-value <0.05
Fully adjusted: baseline LDL, age, sex, race, number of medications, and outpatient utilization visits
Mediation model also adjusts for follow-up medication adherence
RD=Risk Difference
RR=Relative Risk